| Lactose (India) Ltd | 117 Cr. | 92.6 | 137/84.3 | 24.1 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.15 Cr. | 1.65 | 3.51/1.57 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,067 Cr. | 281 | 479/222 | 64.2 | 24.3 | 0.24 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 29.9 Cr. | 38.4 | 72.0/37.2 | | 10.1 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 103 Cr. | 70.2 | 70.2/17.0 | 411 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 62.1 Cr. | 82.5 | 115/69.7 | 17.8 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 61,214 Cr. | 2,171 | 2,298/1,336 | 22.6 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 236 Cr. | 9.70 | 17.2/9.61 | 13.5 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 876 Cr. | 1,633 | 1,999/635 | 25.7 | 294 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 81.2 Cr. | 16.2 | 29.8/16.2 | 23.6 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 944 Cr. | 321 | 399/241 | 10.7 | 133 | 0.78 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.89 Cr. | 13.8 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 6.75 Cr. | 2.71 | 6.11/2.11 | 3.84 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 275 Cr. | 283 | 536/234 | 47.0 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,426 Cr. | 1,013 | 1,511/944 | 38.0 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 38.9 Cr. | 0.19 | 1.12/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 23.3 Cr. | 8.88 | 26.3/7.45 | 11.4 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 6.17 Cr. | 6.11 | 12.7/5.69 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 157 Cr. | 439 | 785/415 | 11.0 | 596 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 71.6 Cr. | 71.6 | 92.5/29.0 | 135 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 12,372 Cr. | 1,182 | 2,150/1,057 | 39.0 | 174 | 0.91 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 5.21 Cr. | 41.4 | 88.7/36.1 | 10.6 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.2 Cr. | 75.0 | 153/75.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 23.5 Cr. | 42.9 | 144/12.2 | 11.4 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 26.2 Cr. | 34.8 | 69.0/33.0 | 42.3 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.06 Cr. | 20.2 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 6,215 Cr. | 358 | 1,028/353 | 21.2 | 72.4 | 0.33 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 73.1 Cr. | 16.9 | 28.8/15.8 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 10.2 Cr. | 20.2 | 30.0/15.9 | 1,024 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 88,277 Cr. | 2,139 | 2,727/2,012 | 50.0 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 232 Cr. | 402 | 524/241 | 22.2 | 123 | 1.12 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 67.8 Cr. | 47.2 | 51.9/26.7 | 91.6 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 75,221 Cr. | 1,296 | 1,320/994 | 21.3 | 603 | 0.31 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 173 Cr. | 277 | 317/159 | 58.5 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 775 Cr. | 77.6 | 115/68.0 | 18.5 | 32.6 | 1.93 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 29.6 Cr. | 22.7 | 39.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 17,049 Cr. | 2,084 | 2,297/930 | 59.4 | 173 | 0.07 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.76 Cr. | 0.72 | 0.97/0.50 | 67.9 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 207 Cr. | 27.0 | 42.0/23.1 | 11.7 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 7.41 Cr. | 12.7 | 19.1/7.60 | 247 | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.62 | 6.80/3.00 | 308 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 57,268 Cr. | 26,960 | 37,000/26,000 | 37.6 | 1,888 | 1.76 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,886 Cr. | 651 | 972/557 | 27.3 | 226 | 0.77 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 183 Cr. | 65.2 | 100/31.3 | 53.4 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 3,801 Cr. | 1,122 | 1,740/752 | | 93.5 | 0.09 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 19,658 Cr. | 1,211 | 1,870/1,154 | 181 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 872 Cr. | 250 | 330/162 | 20.3 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 57.0 Cr. | 6.88 | 29.4/6.58 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,196 Cr. | 894 | 946/278 | 15.7 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,263 Cr. | 323 | 728/309 | 21.5 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,146 Cr. | 828 | 1,402/818 | 16.5 | 768 | 1.21 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,48,619 Cr. | 4,390 | 4,483/3,038 | 64.5 | 250 | 0.73 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 715 Cr. | 78.0 | 179/73.8 | | 41.3 | 0.64 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,135 Cr. | 12.1 | 23.5/11.4 | 16.5 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 11,314 Cr. | 296 | 1,250/267 | 37.6 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,632 Cr. | 138 | 303/113 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,32,335 Cr. | 1,802 | 1,851/1,547 | 35.6 | 324 | 0.89 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 1,937 Cr. | 441 | 734/438 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,473 Cr. | 369 | 434/175 | 39.8 | 81.2 | 0.11 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,102 Cr. | 313 | 502/260 | 34.5 | 125 | 0.16 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 8,068 Cr. | 3,501 | 6,718/3,495 | 23.3 | 326 | 3.34 % | 57.5 % | 43.0 % | 10.0 |
| RPG Life Sciences Ltd | 3,102 Cr. | 1,881 | 2,725/1,764 | 29.5 | 335 | 1.06 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,045 Cr. | 4,849 | 6,739/4,780 | 27.4 | 373 | 2.58 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 119 Cr. | 33.7 | 73.4/30.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,138 Cr. | 4,623 | 5,993/3,701 | 27.8 | 841 | 0.76 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 109 Cr. | 88.6 | 122/81.0 | 7.84 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 1,997 Cr. | 325 | 582/305 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 2,611 Cr. | 512 | 899/489 | 101 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 15,598 Cr. | 12,152 | 19,748/10,060 | 87.1 | 1,263 | 0.10 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 215 Cr. | 11.1 | 28.3/10.9 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 17,119 Cr. | 956 | 1,060/660 | 11.0 | 483 | 0.63 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,087 Cr. | 38.1 | 70.5/33.5 | 27.3 | 21.8 | 0.52 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,563 Cr. | 167 | 271/156 | 21.0 | 59.3 | 0.48 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 49.3 Cr. | 31.7 | 95.0/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 186 Cr. | 52.3 | 129/51.9 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,05,821 Cr. | 2,315 | 2,378/1,774 | 21.3 | 430 | 0.52 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,209 Cr. | 603 | 679/440 | 13.8 | 357 | 0.30 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,218 Cr. | 1,003 | 1,141/517 | 67.7 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,641 Cr. | 1,581 | 1,740/630 | 28.7 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 116 Cr. | 53.4 | 114/50.5 | | 74.6 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 560 Cr. | 116 | 215/116 | 33.8 | 104 | 2.58 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 539 Cr. | 311 | 500/265 | 20.7 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 13,401 Cr. | 844 | 1,250/784 | 29.0 | 414 | 0.59 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 34,063 Cr. | 2,122 | 2,141/1,303 | 45.2 | 243 | 0.73 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,224 Cr. | 183 | 302/155 | 28.7 | 37.9 | 1.37 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 39,643 Cr. | 1,561 | 1,595/1,168 | 37.5 | 293 | 0.26 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,018 Cr. | 68.8 | 127/57.5 | 16.2 | 59.7 | 1.45 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 1,123 Cr. | 137 | 152/67.2 | 23.7 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,815 Cr. | 196 | 350/188 | | 106 | 0.10 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,123 Cr. | 172 | 457/171 | 84.9 | 96.9 | 0.81 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,187 Cr. | 1,401 | 2,350/1,243 | 29.0 | 397 | 0.50 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 2,890 Cr. | 287 | 409/268 | 57.2 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,646 Cr. | 562 | 627/412 | 25.1 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 61,214 Cr. | 2,171 | 2,298/1,336 | 22.6 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 41,073 Cr. | 2,424 | 3,516/2,220 | 40.8 | 101 | 1.73 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 26,781 Cr. | 1,627 | 2,131/1,200 | 22.6 | 610 | 1.11 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 5,743 Cr. | 353 | 528/330 | 24.8 | 149 | 1.42 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 18,311 Cr. | 1,321 | 1,910/1,097 | 41.3 | 227 | 0.56 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,07,881 Cr. | 1,292 | 1,380/1,020 | 19.4 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 2,494 Cr. | 159 | 322/154 | 18.9 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,06,123 Cr. | 1,315 | 1,673/1,282 | 22.3 | 408 | 0.99 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 12,627 Cr. | 1,662 | 2,397/1,551 | 20.6 | 416 | 0.36 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 170 Cr. | 58.2 | 166/57.1 | 7.86 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,150 Cr. | 203 | 244/105 | 19.4 | 107 | 0.25 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 49.7 Cr. | 30.4 | 57.2/28.0 | 17.9 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 62,091 Cr. | 384 | 425/295 | 75.6 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,132 Cr. | 1,116 | 2,000/990 | 26.3 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 110 Cr. | 69.2 | 129/64.0 | 13.5 | 49.2 | 1.73 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 237 Cr. | 99.2 | 205/70.6 | 20.7 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,027 Cr. | 8,401 | 10,691/6,502 | 101 | 320 | 0.38 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,586 Cr. | 546 | 791/540 | 27.4 | 118 | 0.84 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 126 Cr. | 60.9 | 125/55.1 | 10.7 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 63,988 Cr. | 5,356 | 5,934/4,612 | 26.7 | 1,116 | 0.84 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 13,361 Cr. | 678 | 1,108/671 | 20.1 | 271 | 1.62 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 387 Cr. | 676 | 959/642 | 40.3 | 690 | 0.74 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 37,831 Cr. | 3,031 | 3,228/2,022 | 37.3 | 345 | 0.92 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,109 Cr. | 277 | 367/259 | 21.6 | 133 | 1.88 % | 13.1 % | 9.54 % | 2.00 |
| Industry Average | 20,215.05 Cr | 1,070.44 | | 54.25 | 201.81 | 0.39% | 16.35% | 15.16% | 6.10 |